GlassScriptPhysician profile
Mohammad Shakhatreh
NPI 1649430216
$4,413.98
in general payments reported to CMS, 2019-2025
8 companies · $14.02 in 2025
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $85.72 · 2020: $2,711 · 2021: $626 · 2022: $128 · 2023: $835 · 2024: $13.23 · 2025: $14.02.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $494 · Travel and Lodging: $368.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $494.13 |
| Travel and Lodging | $368.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| US Endoscopy | $2,500.00 | 2020 | |
| Apollo Endosurgery US INC | $666.08 | 2023 | Overstitch Endoscopic Suturing System |
| Pinnacle Biologics, INC | $500.00 | 2021 | |
| Conmed Corporation | $214.41 | 2020-2023 | System 2450, Conmed Biliary |
| Olympus America INC. | $189.97 | 2020-2024 | Single Use Electrosurgical Knife Kd-655, Visiglide |
| Boston Scientific Corporation | $158.29 | 2019-2025 | Ensizor |
| Steris Corporation | $94.42 | 2022 | |
| Cook Medical LLC | $90.81 | 2020-2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammad Shakhatreh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.